Epitranscriptomics of cardiovascular diseases (Review)

Manzoni C, Kia DA, Vandrovcova J, Hardy J, Wood NW, Lewis PA and Ferrari R: Genome, transcriptome and proteome: The rise of omics data and their integration in biomedical sciences. Brief Bioinform. 19:286–302. 2018. View Article : Google Scholar :

Buriani A, Fortinguerra S, Sorrenti V, Gabbia D and Carrara M: Single-cell omics in personalized medicine. Single-Cell Omics. Barh D and Azevedo V: Academic Press; Cambridge, MA: pp. 221–236. 2019, View Article : Google Scholar

Korenke GC, Fuchs S, Krasemann E, Doerr HG, Wilichowski E, Hunneman DH and Hanefeld F: Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann Neurol. 40:254–257. 1996. View Article : Google Scholar : PubMed/NCBI

Cavalli G and Heard E: Advances in epigenetics link genetics to the environment and disease. Nature. 571:489–499. 2019. View Article : Google Scholar : PubMed/NCBI

Sarkies P: Molecular mechanisms of epigenetic inheritance: Possible evolutionary implications. Semin Cell Dev Biol. 97:106–115. 2020. View Article : Google Scholar :

Qureshi IA and Mehler MF: Epigenetic mechanisms underlying nervous system diseases. Handb Clin Neurol. 147:43–58. 2018. View Article : Google Scholar : PubMed/NCBI

Schwartz S: Cracking the epitranscriptome. RNA. 22:169–174. 2016. View Article : Google Scholar : PubMed/NCBI

Boccaletto P, Machnicka MA, Purta E, Piatkowski P, Baginski B, Wirecki TK, de Crécy-Lagard V, Ross R, Limbach PA, Kotter A, et al: MODOMICS: A database of RNA modification pathways. 2017 update. Nucleic Acids Res. 46:D303–D307. 2018.

Czerwoniec A, Dunin-Horkawicz S, Purta E, Kaminska KH, Kasprzak JM, Bujnicki JM, Grosjean H and Rother K: MODOMICS: A database of RNA modification pathways. 2008 update. Nucleic Acids Res. 37:D118–D121. 2009. View Article : Google Scholar :

Dunin-Horkawicz S, Czerwoniec A, Gajda MJ, Feder M, Grosjean H and Bujnicki JM: MODOMICS: A database of RNA modification pathways. Nucleic Acids Res. 34:D145–D149. 2006. View Article : Google Scholar :

Machnicka MA, Milanowska K, Osman Oglou O, Purta E, Kurkowska M, Olchowik A, Januszewski W, Kalinowski S, Dunin-Horkawicz S, Rother KM, et al: MODOMICS: A database of RNA modification pathways–2013 update. Nucleic Acids Res. 41:D262–D267. 2013. View Article : Google Scholar

Xuan JJ, Sun WJ, Lin PH, Zhou KR, Liu S, Zheng LL, Qu LH and Yang JH: RMBase v2.0: Deciphering the map of RNA modifications from epitranscriptome sequencing data. Nucleic Acids Res. 46:D327–D334. 2018. View Article : Google Scholar

Kiran AM, O'Mahony JJ, Sanjeev K and Baranov PV: Darned in 2013: Inclusion of model organisms and linking with Wikipedia. Nucleic Acids Res. 41:D258–D261. 2013. View Article : Google Scholar :

Cantara WA, Crain PF, Rozenski J, McCloskey JA, Harris KA, Zhang X, Vendeix FA, Fabris D and Agris PF: The RNA Modification Database, RNAMDB: 2011 update. Nucleic Acids Res. 39:D195–D201. 2011. View Article : Google Scholar

Picardi E, D'Erchia AM, Lo Giudice C and Pesole G: REDIportal: A comprehensive database of A-to-I RNA editing events in humans. Nucleic Acids Res. 45:D750–D757. 2017. View Article : Google Scholar

Schuebel K, Gitik M, Domschke K and Goldman D: Making sense of epigenetics. Int J Neuropsychopharmacol. 19:pyw0582016. View Article : Google Scholar

Kumari R, Ranjan P, Suleiman ZG, Goswami SK, Li J, Prasad R and Verma SK: mRNA modifications in cardiovascular biology and disease: With a focus on m6A modification. Cardiovasc Res. May 6–2021.Epub ahead of print. View Article : Google Scholar

Chen YS, Ouyang XP, Yu XH, Novák P, Zhou L, He P and Yin K: N6-adenosine methylation (m(6)A) RNA modification: An emerging role in cardiovascular diseases. J Cardiovasc Transl Res. Feb 25–2021.Epub ahead of print. View Article : Google Scholar

Napoli C, Benincasa G, Donatelli F and Ambrosio G: Precision medicine in distinct heart failure phenotypes: Focus on clinical epigenetics. Am Heart J. 224:113–128. 2020. View Article : Google Scholar

Fischer MA and Vondriska TM: Clinical epigenomics for cardiovascular disease: Diagnostics and therapies. J Mol Cell Cardiol. 154:97–105. 2021. View Article : Google Scholar : PubMed/NCBI

Schiano C, Benincasa G, Franzese M, Della Mura N, Pane K, Salvatore M and Napoli C: Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases. Pharmacol Ther. 210:1075142020. View Article : Google Scholar

Vlachakis C, Dragoumani K, Raftopoulou S, Mantaiou M, Papageorgiou L, Champeris Tsaniras S, Megalooikonomou V and Vlachakis D: Human emotions on the onset of cardiovascular and small vessel related diseases. In Vivo. 32:859–870. 2018. View Article : Google Scholar : PubMed/NCBI

Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, Mossialos EA, Maggioni AP, Kazakiewicz D, May HT, et al: European Society of Cardiology: European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 41:12–85. 2020. View Article : Google Scholar

Flora GD and Nayak MK: A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des. 25:4063–4084. 2019. View Article : Google Scholar

Baccarelli A, Rienstra M and Benjamin EJ: Cardiovascular epigenetics: Basic concepts and results from animal and human studies. Circ Cardiovasc Genet. 3:567–573. 2010. View Article : Google Scholar

Zhong J, Agha G and Baccarelli AA: The role of DNA methylation in cardiovascular risk and disease: Methodological aspects, study design, and data analysis for epidemiological studies. Circ Res. 118:119–131. 2016. View Article : Google Scholar : PubMed/NCBI

Vlachakis D, Zacharaki EI, Tsiamaki E, Koulouri M, Raftopoulou S, Papageorgiou L, Chrousos GP, Ellul J and Megalooikonomou V: Insights into the molecular mechanisms of stress and inflammation in ageing and frailty of the elderly. J Mol Biochem. 6:41–44. 2017.

Guerra J, Valadao AL, Vlachakis D, Polak K, Vila IK, Taffoni C, Prabakaran T, Marriott AS, Kaczmarek R, Houel A, et al: Lysyl-tRNA synthetase produces diadenosine tetraphosphate to curb STING-dependent inflammation. Sci Adv. 6:eaax33332020. View Article : Google Scholar : PubMed/NCBI

Soler-Botija C, Gálvez-Montón C and Bayés-Genís A: Epigenetic biomarkers in cardiovascular diseases. Front Genet. 10:950. 2019. View Article : Google Scholar

Shi H, Wei J and He C: Where, when, and how: Context-dependent functions of RNA methylation writers, readers, and eras. Mol Cell. 74:640–650. 2019. View Article : Google Scholar

Zaccara S, Ries RJ and Jaffrey SR: Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 20:608–624. 2019. View Article : Google Scholar : PubMed/NCBI

Gatsiou A and Stellos K: Dawn of epitranscriptomic medicine. Circ Genom Precis Med. 11:e0019272018. View Article : Google Scholar : PubMed/NCBI

Anreiter I, Mir Q, Simpson JT, Janga SC and Soller M: New twists in detecting mRNA modification dynamics. Trends Biotechnol. 39:72–89. 2021. View Article : Google Scholar

Mongelli A, Atlante S, Bachetti T, Martelli F, Farsetti A and Gaetano C: Epigenetic signaling and RNA regulation in cardiovascular diseases. Int J Mol Sci. 21:5092020. View Article : Google Scholar :

Zhang P, Wu W, Chen Q and Chen M: Non-coding RNAs and their integrated networks. J Integr Bioinform. 16:162019. View Article : Google Scholar

Gomes CPC, Schroen B, Kuster GM, Robinson EL, Ford K, Squire IB, Heymans S, Martelli F and Emanueli C: Regulatory RNAs in heart failure. Circulation. 141:313–328. 2020. View Article : Google Scholar : PubMed/NCBI

Esteller M and Pandolfi PP: The epitranscriptome of noncoding RNAs in cancer. Cancer Discov. 7:359–368. 2017. View Article : Google Scholar

Blow MJ, Grocock RJ, van Dongen S, Enright AJ, Dicks E, Futreal PA, Wooster R and Stratton MR: RNA editing of human microRNAs. Genome Biol. 7:R272006. View Article : Google Scholar :

Zhang Y, Zang Q, Xu B, Zheng W, Ban R, Zhang H, Yang Y, Hao Q, Iqbal F, Li A, et al: IsomiR Bank: A research resource for tracking IsomiRs. Bioinformatics. 32:2069–2071. 2016. View Article : Google Scholar : PubMed/NCBI

Neilsen CT, Goodall GJ and Bracken CP: IsomiRs - the overlooked repertoire in the dynamic microRNAome. Trends Genet. 28:544–549. 2012. View Article : Google Scholar

Newman MA, Mani V and Hammond SM: Deep sequencing of microRNA precursors reveals extensive 3′ end modification. RNA. 17:1795–1803. 2011. View Article : Google Scholar :

Cloonan N, Wani S, Xu Q, Gu J, Lea K, Heater S, Barbacioru C, Steptoe AL, Martin HC, Nourbakhsh E, et al: MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol. 12:R1262011. View Article : Google Scholar

Manzano M, Forte E, Raja AN, Schipma MJ and Gottwein E: Divergent target recognition by coexpressed 5′-isomiRs of miR-142-3p and selective viral mimicry. RNA. 21:1606–1620. 2015. View Article : Google Scholar : PubMed/NCBI

van der Kwast RV, van Ingen E, Parma L, Peters HA, Quax PH and Nossent AY: Adenosine-to-inosine editing of MicroRNA-487b alters target gene selection after ischemia and promotes Neovascularization. Circ Res. 122:444–456. 2018. View Article : Google Scholar

van der Kwast RV, Woudenberg T, Quax PHA and Nossent AY: MicroRNA-411 and its 5′-IsomiR have distinct targets and functions and are differentially regulated in the vasculature under ischemia. Mol Ther. 28:157–170. 2020. View Article : Google Scholar

Gilbert WV, Bell TA and Schaening C: Messenger RNA modifications: Form, distribution, and function. Science. 352:1408–1412. 2016. View Article : Google Scholar :

Yin L, Zhu X, Novák P, Zhou L, Gao L, Yang M, Zhao G and Yin K: The epitranscriptome of long noncoding RNAs in metabolic diseases. Clin Chim Acta. 515:80–89. 2021. View Article : Google Scholar

Zhou Y, Kong Y, Fan W, Tao T, Xiao Q, Li N and Zhu X: Principles of RNA methylation and their implications for biology and medicine. Biomed Pharmacother. 131:1107312020. View Article : Google Scholar

Wulff BE and Nishikura K: Substitutional A-to-I RNA editing. Wiley Interdiscip Rev RNA. 1:90–101. 2010. View Article : Google Scholar : PubMed/NCBI

Blanc V and Davidson NO: C-to-U RNA editing: Mechanisms leading to genetic diversity. J Biol Chem. 278:1395–1398. 2003. View Article : Google Scholar

Adachi H, De Zoysa MD and Yu YT: Post-transcriptional pseudouridylation in mRNA as well as in some major types of noncoding RNAs. Biochim Biophys Acta Gene Regul Mech. 1862:230–239. 2019. View Article : Google Scholar

Martinet W, De Meyer GR, Herman AG and Kockx MM: RNA damage in human atherosclerosis: Pathophysiological significance and implications for gene expression studies. RNA Biol. 2:4–7. 2005. View Article : Google Scholar

Desrosiers R, Friderici K and Rottman F: Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA. 71:3971–3975. 1974. View Article : Google Scholar

Perry RPK and Kelley DE: Existence of methylated messenger RNA in mouse L cells. Cell. 1:37–42. 1974. View Article : Google Scholar

Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M, et al: Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 485:201–206. 2012. View Article : Google Scholar

Molinie B, Wang J, Lim KS, Hillebrand R, Lu ZX, Van Wittenberghe N, Howard BD, Daneshvar K, Mullen AC, Dedon P, et al: m(6)A-LAIC-seq reveals the census and complexity of the m(6)A epitranscriptome. Nat Methods. 13:692–698. 2016. View Article : Google Scholar

Sun H, Li K, Zhang X, Liu J, Zhang M, Meng H and Yi C: m6Am-seq reveals the dynamic m6Am methylation in the human transcriptome. Nat Commun. 12:47782021. View Article : Google Scholar

Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE and Jaffrey SR: Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell. 149:1635–1646. 2012. View Article : Google Scholar : PubMed/NCBI

Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, et al: N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 505:117–120. 2014. View Article : Google Scholar

Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, Pestova TV, Qian SB and Jaffrey SR: 5′ UTR m(6)a promotes cap-independent translation. Cell. 163:999–1010. 2015. View Article : Google Scholar : PubMed/NCBI

Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H and He C: N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell. 161:1388–1399. 2015. View Article : Google Scholar

Kierzek E and Kierzek R: The thermodynamic stability of RNA duplexes and hairpins containing N6-alkyladenosines and 2-methylthio-N6-alkyladenosines. Nucleic Acids Res. 31:4472–4480. 2003. View Article : Google Scholar : PubMed/NCBI

Liu N, Dai Q, Zheng G, He C, Parisien M and Pan T: N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature. 518:560–564. 2015. View Article : Google Scholar :

Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, Sun HY, Li A, Ping XL, Lai WY, et al: Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol Cell. 61:507–519. 2016. View Article : Google Scholar : PubMed/NCBI

Balatsos NA, Vlachakis D, Maragozidis P, Manta S, Anastasakis D, Kyritsis A, Vlassi M, Komiotis D and Stathopoulos C: Competitive inhibition of human poly(A)-specific ribonuclease (PARN) by synthetic fluoro-pyranosyl nucleosides. Biochemistry. 48:6044–6051. 2009. View Article : Google Scholar

Balatsos N, Vlachakis D, Chatzigeorgiou V, Manta S, Komiotis D, Vlassi M and Stathopoulos C: Kinetic and in silico analysis of the slow-binding inhibition of human poly(A)-specific ribonuclease (PARN) by novel nucleoside analogues. Biochimie. 94:214–221. 2012. View Article : Google Scholar

Fustin JM, Doi M, Yamaguchi Y, Hida H, Nishimura S, Yoshida M, Isagawa T, Morioka MS, Kakeya H, Manabe I, et al: RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell. 155:793–806. 2013. View Article : Google Scholar : PubMed/NCBI

Xiang Y, Laurent B, Hsu CH, Nachtergaele S, Lu Z, Sheng W, Xu C, Chen H, Ouyang J, Wang S, et al: RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature. 543:573–576. 2017. View Article : Google Scholar :

Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, Jia G, Yu M, Lu Z, Deng X, et al: A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 10:93–95. 2014. View Article : Google Scholar :

Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z and Zhao JC: N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol. 16:191–198. 2014. View Article : Google Scholar : PubMed/NCBI

Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, Adhikari S, Shi Y, Lv Y, Chen YS, et al: Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24:177–189. 2014. View Article : Google Scholar :

Schwartz S, Mumbach MR, Jovanovic M, Wang T, Maciag K, Bushkin GG, Mertins P, Ter-Ovanesyan D, Habib N, Cacchiarelli D, et al: Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5′ sites. Cell Rep. 8:284–296. 2014. View Article : Google Scholar :

Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, Gong Z, Wang Q, Huang J, Tang C, et al: Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 534:575–578. 2016. View Article : Google Scholar : PubMed/NCBI

Meyer KD and Jaffrey SR: Rethinking m6A readers, writers, and eras. Annu Rev Cell Dev Biol. 33:319–342. 2017. View Article : Google Scholar

Longenecker JZ, Gilbert CJ, Golubeva VA, Martens CR and Accornero F: Epitranscriptomics in the heart: A focus on m6A. Curr Heart Fail Rep. 17:205–212. 2020. View Article : Google Scholar

Qin Y, Li L, Luo E, Hou J, Yan G, Wang D, Qiao Y and Tang C: Role of m6A RNA methylation in cardiovascular disease (Review). Int J Mol Med. 46:1958–1972. 2020. View Article : Google Scholar

Zheng N, Su J, Hu H, Wang J and Chen X: Research progress of N6-methyladenosine in the cardiovascular system. Med Sci Monit. 26. pp. e9217422020, View Article : Google Scholar

Dorn LE, Lasman L, Chen J, Xu X, Hund TJ, Medvedovic M, Hanna JH, van Berlo JH and Accornero F: The N6-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy. Circulation. 139:533–545. 2019. View Article : Google Scholar :

Song H, Pu J, Wang L, Wu L, Xiao J, Liu Q, Chen J, Zhang M, Liu Y, Ni M, et al: ATG16L1 phosphorylation is oppositely regulated by CSNK2/casein kinase 2 and PPP1/protein phosphatase 1 which determines the fate of cardiomyocytes during hypoxia/reoxygenation. Autophagy. 11:1308–1325. 2015. View Article : Google Scholar : PubMed/NCBI

Pastore N, Brady OA, Diab HI, Martina JA, Sun L, Huynh T, Lim JA, Zare H, Raben N, Ballabio A, et al: TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages. Autophagy. 12:1240–1258. 2016. View Article : Google Scholar

Zhao E and Czaja MJ: Transcription factor EB: A central regulator of both the autophagosome and lysosome. Hepatology. 55:1632–1634. 2012. View Article : Google Scholar : PubMed/NCBI

Song H, Feng X, Zhang H, Luo Y, Huang J, Lin M, Jin J, Ding X, Wu S, Huang H, et al: METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy. 15:1419–1437. 2019. View Article : Google Scholar : PubMed/NCBI

Kmietczyk V, Riechert E, Kalinski L, Boileau E, Malovrh E, Malone B, Gorska A, Hofmann C, Varma E, Jürgensen L, et al: m6A-mRNA methylation regulates cardiac gene expression and cellular growth. Life Sci Alliance. 2:e2018002332019. View Article : Google Scholar :

Berulava T, Buchholz E, Elerdashvili V, Pena T, Islam MR, Lbik D, Mohamed BA, Renner A, von Lewinski D, Sacherer M, et al: Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur J Heart Fail. 22:54–66. 2020. View Article : Google Scholar

Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Brüning JC and Rüther U: Inactivation of the Fto gene protects from obesity. Nature. 458:894–898. 2009. View Article : Google Scholar : PubMed/NCBI

Mathiyalagan P, Adamiak M, Mayourian J, Sassi Y, Liang Y, Agarwal N, Jha D, Zhang S, Kohlbrenner E, Chepurko E, et al: FTO-dependent N6-methyladenosine regulates cardiac function during remodeling and repair. Circulation. 139:518–532. 2019. View Article : Google Scholar

Mathiyalagan P, Adamiak M, Mayourian J, Sassi Y, Liang Y, Agarwal N, Jha D, Shihong Zhang S, Kohlbrenner E, Chepurko E, et al: FTO-dependent m6A regulates cardiac function during remodeling and repair. Circulation. 139:518–532. 2019. View Article : Google Scholar

Michlewski G and Cáceres JF: Post-transcriptional control of miRNA biogenesis. RNA. 25:1–16. 2019. View Article : Google Scholar :

Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH, Wang F, Wang TT, Xu QG, Zhou WP and Sun SH: METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary MicroRNA processing. Hepatology. 65:529–543. 2017. View Article : Google Scholar

Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, et al: METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Mol Cancer. 18:1102019. View Article : Google Scholar :

Baarsma H and Königshoff M: 'WNT-er is coming': WNT signalling in chronic lung diseases. Thorax. 72:746–759. 2017. View Article : Google Scholar

Savai R, Al-Tamari HM, Sedding D, Kojonazarov B, Muecke C, Teske R, Capecchi MR, Weissmann N, Grimminger F, Seeger W, et al: Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension. Nat Med. 20:1289–1300. 2014. View Article : Google Scholar

Lin B, Xu J, Wang F, Wang J, Zhao H and Feng D: LncRNA XIST promotes myocardial infarction by regulating FOS through targeting miR-101a-3p. Aging (Albany NY). 12:7232–7247. 2020. View Article : Google Scholar

Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M and Jaffrey SR: m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 537:369–373. 2016. View Article : Google Scholar

Sun R and Zhang L: Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis. Biomed Pharmacother. 111:1036–1045. 2019. View Article : Google Scholar

Liu N, Parisien M, Dai Q, Zheng G, He C and Pan T: Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. RNA. 19:1848–1856. 2013. View Article : Google Scholar

Spitale RC, Flynn RA, Zhang QC, Crisalli P, Lee B, Jung JW, Kuchelmeister HY, Batista PJ, Torre EA, Kool ET, et al: Erratum: Structural imprints in vivo decode RNA regulatory mechanisms. Nature. 527:2642015. View Article : Google Scholar

Coker H, Wei G and Brockdorff N: m6A modification of non-coding RNA and the control of mammalian gene expression. Biochim Biophys Acta Gene Regul Mech. 1862:310–318. 2019. View Article : Google Scholar

Mendel M, Chen KM, Homolka D, Gos P, Pandey RR, McCarthy AA and Pillai RS: Methylation of structured RNA by the m6A writer METTL16 is essential for mouse embryonic development. Mol Cell. 71:986–1000.e11. 2018. View Article : Google Scholar :

Brown JA, Kinzig CG, DeGregorio SJ and Steitz JA: Methyltransferase-like protein 16 binds the 3′-terminal triple helix of MALAT1 long noncoding RNA. Proc Natl Acad Sci USA. 113:14013–14018. 2016. View Article : Google Scholar

Dunn DB: The occurrence of 1-methyladenine in ribonucleic acid. Biochim Biophys Acta. 46:198–200. 1961. View Article : Google Scholar

Agris PF: The importance of being modified: Roles of modified nucleosides and Mg²⁺ in RNA structure and function. Prog Nucleic Acid Res Mol Biol. 53:79–129. 1996. View Article : Google Scholar

Xiong X, Li X and Yi C: N1-methyladenosine methylome in messenger RNA and non-coding RNA. Curr Opin Chem Biol. 45:179–186. 2018. View Article : Google Scholar : PubMed/NCBI

Waku T, Nakajima Y, Yokoyama W, Nomura N, Kako K, Kobayashi A, Shimizu T and Fukamizu A: NML-mediated rRNA base methylation links ribosomal subunit formation to cell proliferation in a p53-dependent manner. J Cell Sci. 129:2382–2393. 2016.PubMed/NCBI

Chujo T and Suzuki T: Trmt61B is a methyltransferase responsible for 1-methyladenosine at position 58 of human mitochondrial tRNAs. RNA. 18:2269–2276. 2012. View Article : Google Scholar : PubMed/NCBI

Vilardo E, Nachbagauer C, Buzet A, Taschner A, Holzmann J and Rossmanith W: A subcomplex of human mitochondrial RNase P is a bifunctional methyltransferase - extensive moon-lighting in mitochondrial tRNA biogenesis. Nucleic Acids Res. 40:11583–11593. 2012. View Article : Google Scholar : PubMed/NCBI

Ozanick S, Krecic A, Andersland J and Anderson JT: The bipartite structure of the tRNA m1A58 methyltransferase from S. cerevisiae is conserved in humans. RNA. 11:1281–1290. 2005. View Article : Google Scholar : PubMed/NCBI

Zhang C and Jia G: Reversible RNA modification N1-methyladenosine (m1A) in mRNA and tRNA. Genomics Proteomics Bioinformatics. 16:155–161. 2018. View Article : Google Scholar : PubMed/NCBI

Shi Q, Xue C, Yuan X, He Y and Yu Z: Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma. Sci Rep. 10:150832020. View Article : Google Scholar : PubMed/NCBI

Li X, Xiong X, Zhang M, Wang K, Chen Y, Zhou J, Mao Y, Lv J, Yi D, Chen XW, et al: Base-resolution mapping reveals distinct m1A methylome in nuclear- and mitochondrial-encoded transcripts. Mol Cell. 68:993–1005.e9. 2017. View Article : Google Scholar

Siasos G, Tsigkou V, Kosmopoulos M, Theodosiadis D, Simantiris S, Tagkou NM, Tsimpiktsioglou A, Stampouloglou PK, Oikonomou E, Mourouzis K, et al: Mitochondria and cardiovascular diseases-from pathophysiology to treatment. Ann Transl Med. 6:2562018. View Article : Google Scholar : PubMed/NCBI

Poznyak AV, Ivanova EA, Sobenin IA, Yet SF and Orekhov AN: The role of mitochondria in cardiovascular diseases. Biology (Basel). 9:92020.

Ali AT, Idaghdour Y and Hodgkinson A: Analysis of mitochondrial m1A/G RNA modification reveals links to nuclear genetic variants and associated disease processes. Commun Biol. 3:1472020. View Article : Google Scholar : PubMed/NCBI

Xu L, Liu X, Sheng N, Oo KS, Liang J, Chionh YH, Xu J, Ye F, Gao YG, Dedon PC, et al: Three distinct 3-methylcytidine (m3C) methyltransferases modify tRNA and mRNA in mice and humans. J Biol Chem. 292:14695–14703. 2017. View Article : Google Scholar

Chen Z, Qi M, Shen B, Luo G, Wu Y, Li J, Lu Z, Zheng Z, Dai Q and Wang H: Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs. Nucleic Acids Res. 47:2533–2545. 2019. View Article : Google Scholar

Ma CJ, Ding JH, Ye TT, Yuan BF, Feng YQ and Alk B: AlkB homologue 1 demethylates N3-methylcytidine in mRNA of mammals. ACS Chem Biol. 14:1418–1425. 2019. View Article : Google Scholar

Lentini JM, Alsaif HS, Faqeih E, Alkuraya FS and Fu D: DALRD3 encodes a protein mutated in epileptic encephalopathy that targets arginine tRNAs for 3-methylcytosine modification. Nat Commun. 11:25102020. View Article : Google Scholar :

Yang X, Yang Y, Sun BF, Chen YS, Xu JW, Lai WY, Li A, Wang X, Bhattarai DP, Xiao W, et al: 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m5C reader. Cell Res. 27:606–625. 2017. View Article : Google Scholar : PubMed/NCBI

Gambaryan AS, Venkstern TV and Baev AA: Use of the method of mixed substrates to study the specificity of tRNA methylases. Mol Biol (Mosk). 10:697–705. 1976.

Amort T, Rieder D, Wille A, Khokhlova-Cubberley D, Riml C, Trixl L, Jia XY, Micura R and Lusser A: Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain. Genome Biol. 18:12017. View Article : Google Scholar

Squires JE, Patel HR, Nousch M, Sibbritt T, Humphreys DT, Parker BJ, Suter CM and Preiss T: Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 40:5023–5033. 2012. View Article : Google Scholar : PubMed/NCBI

Sharma S, Yang J, Watzinger P, Kötter P and Entian KD: Yeast Nop2 and Rcm1 methylate C2870 and C2278 of the 25S rRNA, respectively. Nucleic Acids Res. 41:9062–9076. 2013. View Article : Google Scholar :

Brzezicha B, Schmidt M, Makalowska I, Jarmolowski A, Pienkowska J and Szweykowska-Kulinska Z: Identification of human tRNA:m5C methyltransferase catalysing intron-dependent m5C formation in the first position of the anticodon of the pre-tRNA Leu (CAA). Nucleic Acids Res. 34:6034–6043. 2006. View Article : Google Scholar : PubMed/NCBI

Hussain S, Sajini AA, Blanco S, Dietmann S, Lombard P, Sugimoto Y, Paramor M, Gleeson JG, Odom DT, Ule J, et al: NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs. Cell Rep. 4:255–261. 2013. View Article : Google Scholar : PubMed/NCBI

Haag S, Sloan KE, Ranjan N, Warda AS, Kretschmer J, Blessing C, Hübner B, Seikowski J, Dennerlein S, Rehling P, et al: NSUN3 and ABH1 modify the wobble position of mt-tRNAMet to expand codon recognition in mitochondrial translation. EMBO J. 35:2104–2119. 2016. View Article : Google Scholar : PubMed/NCBI

Metodiev MD, Spåhr H, Loguercio Polosa P, Meharg C, Becker C, Altmueller J, Habermann B, Larsson NG and Ruzzenente B: NSUN4 is a dual function mitochondrial protein required for both methylation of 12S rRNA and coordination of mitoribosomal assembly. PLoS Genet. 10:e10041102014. View Article : Google Scholar : PubMed/NCBI

Schosserer M, Minois N, Angerer TB, Amring M, Dellago H, Harreither E, Calle-Perez A, Pircher A, Gerstl MP, Pfeifenberger S, et al: Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan. Nat Commun. 6:61582015. View Article : Google Scholar

Haag S, Warda AS, Kretschmer J, Günnigmann MA, Höbartner C and Bohnsack MT: NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs. RNA. 21:1532–1543. 2015. View Article : Google Scholar :

Kaiser S, Jurkowski TP, Kellner S, Schneider D, Jeltsch A and Helm M: The RNA methyltransferase Dnmt2 methylates DNA in the structural context of a tRNA. RNA Biol. 14:1241–1251. 2017. View Article : Google Scholar

Goll MG, Kirpekar F, Maggert KA, Yoder JA, Hsieh CL, Zhang X, Golic KG, Jacobsen SE and Bestor TH: Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science. 311:395–398. 2006. View Article : Google Scholar

Abbasi-Moheb L, Mertel S, Gonsior M, Nouri-Vahid L, Kahrizi K, Cirak S, Wieczorek D, Motazacker MM, Esmaeeli-Nieh S, Cremer K, et al: Mutations in NSUN2 cause autosomal-recessive intellectual disability. Am J Hum Genet. 90:847–855. 2012. View Article : Google Scholar

Frye M and Watt FM: The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors. Curr Biol. 16:971–981. 2006. View Article : Google Scholar : PubMed/NCBI

Yi J, Gao R, Chen Y, Yang Z, Han P, Zhang H, Dou Y, Liu W, Wang W, Du G, et al: Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer. Oncotarget. 8:20751–20765. 2017. View Article : Google Scholar

Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, Cole CG, Ward S, Dawson E, Ponting L, et al: COSMIC: Somatic cancer genetics at high-resolution. Nucleic Acids Res. 45:D777–D783. 2017. View Article : Google Scholar

Elhardt W, Shanmugam R, Jurkowski TP and Jeltsch A: Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties. Biochimie. 112:66–72. 2015. View Article : Google Scholar

Ghanbarian H, Wagner N, Polo B, Baudouy D, Kiani J, Michiels JF, Cuzin F, Rassoulzadegan M and Wagner KD: Dnmt2/Trdmt1 as mediator of RNA polymerase II transcriptional activity in cardiac growth. PLoS One. 11:e01569532016. View Article : Google Scholar :

Luo Y, Feng J, Xu Q, Wang W and Wang X: NSun2 deficiency protects endothelium from inflammation via mRNA methylation of ICAM-1. Circ Res. 118:944–956. 2016. View Article : Google Scholar

Wang N, Tang H, Wang X, Wang W and Feng J: Homocysteine upregulates interleukin-17A expression via NSun2-mediated RNA methylation in T lymphocytes. Biochem Biophys Res Commun. 493:94–99. 2017. View Article : Google Scholar : PubMed/NCBI

Yuan S, Tang H, Xing J, Fan X, Cai X, Li Q, Han P, Luo Y, Zhang Z, Jiang B, et al: Methylation by NSun2 represses the levels and function of microRNA 125b. Mol Cell Biol. 34:3630–3641. 2014. View Article : Google Scholar : PubMed/NCBI

Wen P, Cao H, Fang L, Ye H, Zhou Y, Jiang L, Su W, Xu H, He W, Dai C, et al: miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment. Exp Cell Res. 322:302–312. 2014. View Article : Google Scholar : PubMed/NCBI

Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR and Hofbauer LC: miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol. 179:1594–1600. 2011. View Article : Google Scholar :

Trixl L and Lusser A: The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark. Wiley Interdiscip Rev RNA. 10:e15102019. View Article : Google Scholar

Jacob R, Zander S and Gutschner T: The dark side of the epitranscriptome: Chemical modifications in long non-coding RNAs. Int J Mol Sci. 18:182017. View Article : Google Scholar

Fu L, Guerrero CR, Zhong N, Amato NJ, Liu Y, Liu S, Cai Q, Ji D, Jin SG, Niedernhofer LJ, et al: Tet-mediated formation of 5-hydroxymethylcytosine in RNA. J Am Chem Soc. 136:11582–11585. 2014. View Article : Google Scholar :

Fang S, Li J, Xiao Y, Lee M, Guo L, Han W, Li T, Hill MC, Hong T, Mo W, et al: Tet inactivation disrupts YY1 binding and long-range chromatin interactions during embryonic heart development. Nat Commun. 10:42972019. View Article : Google Scholar :

Ramanathan A, Robb GB and Chan S-H: mRNA capping: Biological functions and applications. Nucleic Acids Res. 44:7511–7526. 2016. View Article : Google Scholar : PubMed/NCBI

Furuichi Y: Discovery of m(7)G-cap in eukaryotic mRNAs. Proc Jpn Acad, Ser B, Phys Biol Sci. 91:394–409. 2015. View Article : Google Scholar

Pandolfini L, Barbieri I, Bannister AJ, Hendrick A, Andrews B, Webster N, Murat P, Mach P, Brandi R, Robson SC, et al: METTL1 promotes let-7 MicroRNA processing via m7G methylation. Mol Cell. 74:1278–1290.e9. 2019. View Article : Google Scholar :

Bao MH, Feng X, Zhang YW, Lou XY, Cheng Y and Zhou HH: Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int J Mol Sci. 14:23086–23102. 2013. View Article : Google Scholar : PubMed/NCBI

Bernstein DL, Jiang X and Rom S: let-7 microRNAs: Their role in cerebral and cardiovascular diseases, inflammation, cancer, and their regulation. Biomedicines. 9:92021. View Article : Google Scholar

Tolonen A-M, Magga J, Szabó Z, Viitala P, Gao E, Moilanen AM, Ohukainen P, Vainio L, Koch WJ, Kerkelä R, et al: Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice. Pharmacol Res Perspect. 2:e00056. 2014. View Article : Google Scholar

Yang Y, Ago T, Zhai P, Abdellatif M and Sadoshima J: Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res. 108:305–313. 2011. View Article : Google Scholar

Satoh M, Minami Y, Takahashi Y, Tabuchi T and Nakamura M: A cellular microRNA, let-7i, is a novel biomarker for clinical outcome in patients with dilated cardiomyopathy. J Card Fail. 17:923–929. 2011. View Article : Google Scholar

Dimitrova DG, Teysset L and Carré C: RNA 2′-O-Methylation (Nm) modification in human diseases. Genes (Basel). 10:102019. View Article : Google Scholar

Somme J, Van Laer B, Roovers M, Steyaert J, Versées W and Droogmans L: Characterization of two homologous 2′-O-methyltransferases showing different specificities for their tRNA substrates. RNA. 20:1257–1271. 2014. View Article : Google Scholar

Cavaillé J, Nicoloso M and Bachellerie J-P: Targeted ribose methylation of RNA in vivo directed by tailored antisense RNA guides. Nature. 383:732–735. 1996. View Article : Google Scholar

O'Brien JE Jr, Kibiryeva N, Zhou X-G, Marshall JA, Lofland GK, Artman M, Chen J and Bittel DC: Noncoding RNA expression in myocardium from infants with tetralogy of Fallot. Circ Cardiovasc Genet. 5:279–286. 2012. View Article : Google Scholar

Nagasawa C, Ogren A, Kibiryeva N, Marshall J, O'Brien JE Jr, Kenmochi N and Bittel DC: The role of scaRNAs in adjusting alternative mRNA splicing in heart development. J Cardiovasc Dev Dis. 5:262018. View Article : Google Scholar

Elliott BA, Ho H-T, Ranganathan SV, Vangaveti S, Ilkayeva O, Abou Assi H, Choi AK, Agris PF and Holley CL: Modification of messenger RNA by 2′-O-methylation regulates gene expression in vivo. Nat Commun. 10:34012019. View Article : Google Scholar

Gagnidze K, Rayon-Estrada V, Harroch S, Bulloch K and Papavasiliou FN: A new chapter in genetic medicine: RNA Editing and its role in disease pathogenesis. Trends Mol Med. 24:294–303. 2018. View Article : Google Scholar

Nishikura K: A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol. 17:83–96. 2016. View Article : Google Scholar :

Uchida S and Jones SP: RNA editing: Unexplored opportunities in the cardiovascular system. Circ Res. 122:399–401. 2018. View Article : Google Scholar : PubMed/NCBI

Picardi E, Manzari C, Mastropasqua F, Aiello I, D'Erchia AM and Pesole G: Profiling RNA editing in human tissues: Towards the inosinome Atlas. Sci Rep. 5:149412015. View Article : Google Scholar :

Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, et al: Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 111:897–906. 2003. View Article : Google Scholar

Wang B, Sun J, Kitamoto S, Yang M, Grubb A, Chapman HA, Kalluri R and Shi GP: Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem. 281:6020–6029. 2006. View Article : Google Scholar

Zhu Y, Pirnie SP and Carmichael GG: High-throughput and site-specific identification of 2′-O-methylation sites using ribose oxidation sequencing (RibOxi-seq). RNA. 23:1303–1314. 2017. View Article : Google Scholar : PubMed/NCBI

Stellos K, Gatsiou A, Stamatelopoulos K, Perisic Matic L, John D, Lunella FF, Jaé N, Rossbach O, Amrhein C, Sigala F, et al: Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation. Nat Med. 22:1140–1150. 2016. View Article : Google Scholar : PubMed/NCBI

Wang Y, Men M, Xie B, Shan J, Wang C, Liu J, Zheng H, Yang W, Xue S and Guo C: Inhibition of PKR protects against H₂O₂-induced injury on neonatal cardiac myocytes by attenuating apoptosis and inflammation. Sci Rep. 6:387532016. View Article : Google Scholar

Moore JB IV, Sadri G, Fischer AG, Weirick T, Militello G, Wysoczynski M, Gumpert AM, Braun T and Uchida S: The A-to-I RNA editing enzyme Adar1 is essential for normal embryonic cardiac growth and development. Circ Res. 127:550–552. 2020. View Article : Google Scholar :

El Azzouzi H, Vilaça AP, Feyen DA, Gommans WM, de Weger RA, Doevendans PA and Sluijter JP: Cardiomyocyte specific deletion of ADAR1 causes severe cardiac dysfunction and increased lethality. Front Cardiovasc Med. 7:302020. View Article : Google Scholar

Stulić M and Jantsch MF: Spatio-temporal profiling of Filamin A RNA-editing reveals ADAR preferences and high editing levels outside neuronal tissues. RNA Biol. 10:1611–1617. 2013. View Article : Google Scholar

Jain M, Mann TD, Stulić M, Rao SP, Kirsch A, Pullirsch D, Strobl X, Rath C, Reissig L, Moreth K, et al: RNA editing of Filamin A pre-mRNA regulates vascular contraction and diastolic blood pressure. EMBO J. 37:372018. View Article : Google Scholar

Vu LT and Tsukahara T: C-to-U editing and site-directed RNA editing for the correction of genetic mutations. Biosci Trends. 11:243–253. 2017. View Article : Google Scholar

Gerber AP and Keller W: RNA editing by base deamination: More enzymes, more targets, new mysteries. Trends Biochem Sci. 26:376–384. 2001. View Article : Google Scholar

Rosenberg BR, Dewell S and Papavasiliou FN: Identifying mRNA editing deaminase targets by RNA-Seq. Methods Mol Biol. 718:103–119. 2011. View Article : Google Scholar

Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ and Scott J: A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell. 50:831–840. 1987. View Article : Google Scholar : PubMed/NCBI

Teng B, Burant CF and Davidson NO: Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 260:1816–1819. 1993. View Article : Google Scholar

Blanc V and Davidson NO: APOBEC-1-mediated RNA editing. Wiley Interdiscip Rev Syst Biol Med. 2:594–602. 2010. View Article : Google Scholar

Anant S, Henderson JO, Mukhopadhyay D, Navaratnam N, Kennedy S, Min J and Davidson NO: Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J Biol Chem. 276:47338–47351. 2001. View Article : Google Scholar : PubMed/NCBI

Blech-Hermoni Y, Dasgupta T, Coram RJ and Ladd AN: Identification of targets of CUG-BP, Elav-like family member 1 (CELF1) regulation in embryonic heart muscle. PLoS One. 11:e01490612016. View Article : Google Scholar : PubMed/NCBI

Giudice J, Xia Z, Li W and Cooper TA: Neonatal cardiac dysfunction and transcriptome changes caused by the absence of Celf1. Sci Rep. 6:355502016. View Article : Google Scholar

Liao W, Hong SH, Chan BH, Rudolph FB, Clark SC and Chan L: APOBEC-2, a cardiac - and skeletal muscle-specific member of the cytidine deaminase supergene family. Biochem Biophys Res Commun. 260:398–404. 1999. View Article : Google Scholar : PubMed/NCBI

Sharma S, Patnaik SK, Taggart RT, Kannisto ED, Enriquez SM, Gollnick P and Baysal BE: APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages. Nat Commun. 6:68812015. View Article : Google Scholar : PubMed/NCBI

Sharma S, Patnaik SK, Kemer Z and Baysal BE: Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes. RNA Biol. 14:603–610. 2017. View Article : Google Scholar :

Li X, Ma S and Yi C: Pseudouridine: The fifth RNA nucleotide with renewed interests. Curr Opin Chem Biol. 33:108–116. 2016. View Article : Google Scholar

Cohn WE and Volkin E: Nucleoside-5′-phosphates from ribonucleic acid. Nature. 167:483–484. 1951. View Article : Google Scholar

Sengupta R, Vainauskas S, Yarian C, Sochacka E, Malkiewicz A, Guenther RH, Koshlap KM and Agris PF: Modified constructs of the tRNA TPsiC domain to probe substrate conformational requirements of m(1)A(58) and m(5)U(54) tRNA methyltransferases. Nucleic Acids Res. 28:1374–1380. 2000. View Article : Google Scholar

Charette M and Gray MW: Pseudouridine in RNA: What, where, how, and why. IUBMB Life. 49:341–351. 2000. View Article : Google Scholar

Davis DR: Stabilization of RNA stacking by pseudouridine. Nucleic Acids Res. 23:5020–5026. 1995. View Article : Google Scholar

Karijolich J and Yu YT: Converting nonsense codons into sense codons by targeted pseudouridylation. Nature. 474:395–398. 2011. View Article : Google Scholar : PubMed/NCBI

Spenkuch F, Motorin Y and Helm M: Pseudouridine: Still mysterious, but never a fake (uridine)! RNA Biol. 11:1540–1554. 2014. View Article : Google Scholar

Safra M, Nir R, Farouq D, Vainberg Slutskin I and Schwartz S: TRUB1 is the predominant pseudouridine synthase acting on mammalian mRNA via a predictable and conserved code. Genome Res. 27:393–406. 2017. View Article : Google Scholar

Antonicka H, Choquet K, Lin ZY, Gingras AC, Kleinman CL and Shoubridge EA: A pseudouridine synthase module is essential for mitochondrial protein synthesis and cell viability. EMBO Rep. 18:28–38. 2017. View Article : Google Scholar

Zaganelli S, Rebelo-Guiomar P, Maundrell K, Rozanska A, Pierredon S, Powell CA, Jourdain AA, Hulo N, Lightowlers RN, Chrzanowska-Lightowlers ZM, et al: The pseudouridine synthase RPUSD4 is an essential component of mitochondrial RNA granules. J Biol Chem. 292:4519–4532. 2017. View Article : Google Scholar : PubMed/NCBI

Mei YP, Liao JP, Shen J, Yu L, Liu BL, Liu L, Li RY, Ji L, Dorsey SG, Jiang ZR, et al: Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene. 31:2794–2804. 2012. View Article : Google Scholar

Bykhovskaya Y, Casas K, Mengesha E, Inbal A and Fischel-Ghodsian N: Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet. 74:1303–1308. 2004. View Article : Google Scholar

Zucchini C, Strippoli P, Biolchi A, Solmi R, Lenzi L, D'Addabbo P, Carinci P and Valvassori L: The human TruB family of pseudouridine synthase genes, including the Dyskeratosis Congenita 1 gene and the novel member TRUB1. Int J Mol Med. 11:697–704. 2003.PubMed/NCBI

Jády BE and Kiss T: A small nucleolar guide RNA functions both in 2′-O-ribose methylation and pseudouridylation of the U5 spliceosomal RNA. EMBO J. 20:541–551. 2001. View Article : Google Scholar

Darzacq X, Jády BE, Verheggen C, Kiss AM, Bertrand E and Kiss T: Cajal body-specific small nuclear RNAs: A novel class of 2′-O-methylation and pseudouridylation guide RNAs. EMBO J. 21:2746–2756. 2002. View Article : Google Scholar : PubMed/NCBI

Nagasawa CK, Kibiryeva N, Marshall J, O'Brien JE Jr and Bittel DC: scaRNA1 levels alter pseudouridylation in spliceosomal RNA U2 affecting alternative mRNA splicing and embryonic development. Pediatr Cardiol. 41:341–349. 2020. View Article : Google Scholar : PubMed/NCBI

Wilusz JE: Long noncoding RNAs: Re-writing dogmas of RNA processing and stability. Biochim Biophys Acta. 1859:128–138. 2016. View Article : Google Scholar

Kanvah S, Joseph J, Schuster GB, Barnett RN, Cleveland CL and Landman U: Oxidation of DNA: Damage to nucleobases. Acc Chem Res. 43:280–287. 2010. View Article : Google Scholar

Faucher F, Doublié S and Jia Z: 8-oxoguanine DNA glycosylases: One lesion, three subfamilies. Int J Mol Sci. 13:6711–6729. 2012. View Article : Google Scholar : PubMed/NCBI

Shah A, Gray K, Figg N, Finigan A, Starks L and Bennett M: Defective base excision repair of oxidative DNA damage in vascular smooth muscle cells promotes atherosclerosis. Circulation. 138:1446–1462. 2018. View Article : Google Scholar : PubMed/NCBI

Seok H, Lee H, Lee S, Ahn SH, Lee HS, Kim GD, Peak J, Park J, Cho YK, Jeong Y, et al: Position-specific oxidation of miR-1 encodes cardiac hypertrophy. Nature. 584:279–285. 2020. View Article : Google Scholar

Wang J, Wang Q, Watson LJ, Jones SP and Epstein PN: Cardiac overexpression of 8-oxoguanine DNA glycosylase 1 protects mitochondrial DNA and reduces cardiac fibrosis following transaortic constriction. Am J Physiol Heart Circ Physiol. 301:H2073–H2080. 2011. View Article : Google Scholar :

Noren Hooten N, Ejiogu N, Zonderman AB and Evans MK: Association of oxidative DNA damage and C-reactive protein in women at risk for cardiovascular disease. Arterioscler Thromb Vasc Biol. 32:2776–2784. 2012. View Article : Google Scholar : PubMed/NCBI

Motorin Y and Helm M: RNA nucleotide methylation. Wiley Interdiscip Rev RNA. 2:611–631. 2011. View Article : Google Scholar

Garcia-Campos MA, Edelheit S, Toth U, Safra M, Shachar R, Viukov S, Winkler R, Nir R, Lasman L, Brandis A, et al: Deciphering the 'm6A Code' via antibody-independent quantitative profiling. Cell. 178:731–747.e16. 2019. View Article : Google Scholar

Zhang Z, Chen L-Q, Zhao Y-L, Yang CG, Roundtree IA, Zhang Z, Ren J, Xie W, He C and Luo GZ: Single-base mapping of m6A by an antibody-independent method. Sci Adv. 5:eaax02502019. View Article : Google Scholar :

Liu N and Pan T: Probing N6-methyladenosine (m6A) RNA modification in total RNA with SCARLET. Methods Mol Biol. 1358:285–292. 2016. View Article : Google Scholar

Dominissini D, Moshitch-Moshkovitz S, Salmon-Divon M, Amariglio N and Rechavi G: Transcriptome-wide mapping of N(6)-methyladenosine by m(6)A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc. 8:176–189. 2013. View Article : Google Scholar : PubMed/NCBI

Chen K, Lu Z, Wang X, Fu Y, Luo GZ, Liu N, Han D, Dominissini D, Dai Q, Pan T, et al: High-resolution N(6)-methyladenosine (m(6) A) map using photo-crosslinking-assisted m(6) A sequencing. Angew Chem Int Ed Engl. 54:1587–1590. 2015. View Article : Google Scholar

Marchand V, Bourguignon-Igel V, Helm M and Motorin Y: Analysis of pseudouridines and other RNA modifications using HydraPsiSeq protocol. Methods. Sep 1–2021.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI

Motorin Y and Helm M: Methods for RNA modification mapping using deep sequencing: Established and new emerging technologies. Genes (Basel). 10:352019. View Article : Google Scholar

Dai Q, Moshitch-Moshkovitz S, Han D, Kol N, Amariglio N, Rechavi G, Dominissini D and He C: Nm-seq maps 2′-O-methylation sites in human mRNA with base precision. Nat Methods. 14:695–698. 2017. View Article : Google Scholar : PubMed/NCBI

Birkedal U, Christensen-Dalsgaard M, Krogh N, Sabarinathan R, Gorodkin J and Nielsen H: Profiling of ribose methylations in RNA by high-throughput sequencing. Angew Chem Int Ed Engl. 54:451–455. 2015.

Yoluç Y, Ammann G, Barraud P, Jora M, Limbach PA, Motorin Y, Marchand V, Tisné C, Borland K and Kellner S: Instrumental analysis of RNA modifications. Crit Rev Biochem Mol Biol. 56:178–204. 2021. View Article : Google Scholar : PubMed/NCBI

Huang TY, Liu J and McLuckey SA: Top-down tandem mass spectrometry of tRNA via ion trap collision-induced dissociation. J Am Soc Mass Spectrom. 21:890–898. 2010. View Article : Google Scholar : PubMed/NCBI

Durairaj A and Limbach PA: Improving CMC-derivatization of pseudouridine in RNA for mass spectrometric detection. Anal Chim Acta. 612:173–181. 2008. View Article : Google Scholar : PubMed/NCBI

Kowalak JA, Pomerantz SC, Crain PF and McCloskey JA: A novel method for the determination of post-transcriptional modification in RNA by mass spectrometry. Nucleic Acids Res. 21:4577–4585. 1993. View Article : Google Scholar : PubMed/NCBI

Heiss M, Borland K, Yoluç Y and Kellner S: Quantification of Modified nucleosides in the context of NAIL-MS. Methods Mol Biol. 2298:279–306. 2021. View Article : Google Scholar

Wein S, Andrews B, Sachsenberg T, Santos-Rosa H, Kohlbacher O, Kouzarides T, Garcia BA and Weisser H: A computational platform for high-throughput analysis of RNA sequences and modifications by mass spectrometry. Nat Commun. 11:9262020. View Article : Google Scholar : PubMed/NCBI

Marceca GP, Tomasello L, Distefano R, Acunzo M, Croce CM and Nigita G: Detecting and characterizing A-To-I microRNA editing in cancer. Cancers (Basel). 13:16992021. View Article : Google Scholar

Okada S, Ueda H, Noda Y and Suzuki T: Transcriptome-wide identification of A-to-I RNA editing sites using ICE-seq. Methods. 156:66–78. 2019. View Article : Google Scholar

Adachi H, DeZoysa MD and Yu YT: Detection and quantification of pseudouridine in RNA. Epitranscriptomics: Methods and Protocols. Wajapeyee N and Gupta R: Springer; New York, NY: pp. 219–235. 2019, View Article : Google Scholar

Schwartz S, Bernstein DA, Mumbach MR, Jovanovic M, Herbst RH, León-Ricardo BX, Engreitz JM, Guttman M, Satija R, Lander ES, et al: Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell. 159:148–162. 2014. View Article : Google Scholar : PubMed/NCBI

Lovejoy AF, Riordan DP and Brown PO: Transcriptome-wide mapping of pseudouridines: Pseudouridine synthases modify specific mRNAs in S. cerevisiae. PLoS One. 9:e1107992014. View Article : Google Scholar : PubMed/NCBI

Carlile TM, Rojas-Duran MF, Zinshteyn B, Shin H, Bartoli KM and Gilbert WV: Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature. 515:143–146. 2014. View Article : Google Scholar : PubMed/NCBI

Li X, Zhu P, Ma S, Song J, Bai J, Sun F and Yi C: Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome. Nat Chem Biol. 11:592–597. 2015. View Article : Google Scholar : PubMed/NCBI

Banerjee A, Mikhailova E, Cheley S, Gu LQ, Montoya M, Nagaoka Y, Gouaux E and Bayley H: Molecular bases of cyclodextrin adapter interactions with engineered protein nanopores. Proc Natl Acad Sci USA. 107:8165–8170. 2010. View Article : Google Scholar : PubMed/NCBI

Wang Y, Yang Q and Wang Z: The evolution of nanopore sequencing. Front Genet. 5:449. 2015. View Article : Google Scholar : PubMed/NCBI

Simpson JT, Workman RE, Zuzarte PC, David M, Dursi LJ and Timp W: Detecting DNA cytosine methylation using nanopore sequencing. Nat Methods. 14:407–410. 2017. View Article : Google Scholar : PubMed/NCBI

Vlachakis D, Papakonstantinou E, Sagar R, Bacopoulou F, Exarchos T, Kourouthanassis P, Karyotis V, Vlamos P, Lyketsos C, Avramopoulos D, et al: Improving the utility of polygenic risk scores as a biomarker for Alzheimer's disease. Cells. 10:16272021. View Article : Google Scholar : PubMed/NCBI

Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, McMahon A, Morales J, Mountjoy E, Sollis E, et al: The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47:D1005–D1012. 2019. View Article : Google Scholar

Zheng Y, Nie P, Peng D, He Z, Liu M, Xie Y, Miao Y, Zuo Z and Ren J: m6AVar: A database of functional variants involved in m6A modification. Nucleic Acids Res. 46:D139–D145. 2018. View Article : Google Scholar :

Jiang S, Xie Y, He Z, Zhang Y, Zhao Y, Chen L, Zheng Y, Miao Y, Zuo Z and Ren J: m6ASNP: A tool for annotating genetic variants by m6A function. Gigascience. 7:72018. View Article : Google Scholar

Song B, Tang Y, Chen K, Wei Z, Rong R, Lu Z, Su J, de Magalhães JP, Rigden DJ and Meng J: m7GHub: Deciphering the location, regulation and pathogenesis of internal mRNA N7-methylguanosine (m7G) sites in human. Bioinformatics. 36:3528–3536. 2020. View Article : Google Scholar : PubMed/NCBI

Chen K, Song B, Tang Y, Wei Z, Xu Q, Su J, de Magalhães JP, Rigden DJ and Meng J: RMDisease: A database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis. Nucleic Acids Res. 49:D1396–D1404. 2021. View Article : Google Scholar

Incarnato D, Morandi E, Simon LM and Oliviero S: RNA Framework: An all-in-one toolkit for the analysis of RNA structures and post-transcriptional modifications. Nucleic Acids Res. 46:e972018. View Article : Google Scholar : PubMed/NCBI

Mo XB, Lei SF, Zhang YH and Zhang H: Detection of m6A-associated SNPs as potential functional variants for coronary artery disease. Epigenomics. 10:1279–1287. 2018. View Article : Google Scholar : PubMed/NCBI

Mo XB, Lei SF, Zhang YH and Zhang H: Examination of the associations between m6A-associated single-nucleotide polymorphisms and blood pressure. Hypertens Res. 42:1582–1589. 2019. View Article : Google Scholar : PubMed/NCBI

Mo X, Lei S, Zhang Y and Zhang H: Genome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci. Pharmacogenomics J. 19:347–357. 2019. View Article : Google Scholar

Mo X-B, Lei S-F, Zhang Y-H and Zhang H: Integrative Analysis identified IRF6 and NDST1 as potential causal genes for ischemic stroke. Front Neurol. 10:5172019. View Article : Google Scholar :

Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, Herron TJ, McCarthy S, Schmidt EM, Sveinbjornsson G, et al: Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 50:1234–1239. 2018. View Article : Google Scholar

Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T, Thorleifsson G, Luan J, Donnelly LA, Kanoni S, et al CHARGE-EchoGen consortium; CHARGE-HF consortium: Wellcome Trust Case Control Consortium: The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet. 48:1171–1184. 2016. View Article : Google Scholar :

Franzén O, Ermel R, Sukhavasi K, Jain R, Jain A, Betsholtz C, Giannarelli C, Kovacic JC, Ruusalepp A, Skogsberg J, et al: Global analysis of A-to-I RNA editing reveals association with common disease variants. PeerJ. 6:e4466. 2018. View Article : Google Scholar :

Lee JY, Lee BS, Shin DJ, Woo Park K, Shin YA, Joong Kim K, Heo L, Young Lee J, Kyoung Kim Y, Jin Kim Y, et al: A genome-wide association study of a coronary artery disease risk variant. J Hum Genet. 58:120–126. 2013. View Article : Google Scholar : PubMed/NCBI

Jeemon P, Pettigrew K, Sainsbury C, Prabhakaran D and Padmanabhan S: Implications of discoveries from genome-wide association studies in current cardiovascular practice. World J Cardiol. 3:230–247. 2011. View Article : Google Scholar : PubMed/NCBI

Wakil SM, Ram R, Muiya NP, Mehta M, Andres E, Mazhar N, Baz B, Hagos S, Alshahid M, Meyer BF, et al: A genome-wide association study reveals susceptibility loci for myocardial infarction/coronary artery disease in Saudi Arabs. Atherosclerosis. 245:62–70. 2016. View Article : Google Scholar

Terasawa Y, Ladha Z, Leonard SW, Morrow JD, Newland D, Sanan D, Packer L, Traber MG and Farese RV Jr: Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E. Proc Natl Acad Sci USA. 97:13830–13834. 2000. View Article : Google Scholar

Lu N, Li X, Yu J, Li Y, Wang C, Zhang L, Wang T and Zhong X: Curcumin attenuates lipopolysaccharide-induced hepatic lipid metabolism disorder by modification of m6A RNA methylation in piglets. Lipids. 53:53–63. 2018. View Article : Google Scholar

Sikorski V, Karjalainen P, Blokhina D, Oksaharju K, Khan J, Katayama S, Rajala H, Suihko S, Tuohinen S, Teittinen K, et al: Epitranscriptomics of ischemic heart disease-the IHD-EPITRAN study design and objectives. Int J Mol Sci. 22:222021. View Article : Google Scholar

Huang Y, Yan J, Li Q, Li J, Gong S, Zhou H, Gan J, Jiang H, Jia GF, Luo C, et al: Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 43:373–384. 2015. View Article : Google Scholar

Li J, Chen Z, Chen F, Xie G, Ling Y, Peng Y, Lin Y, Luo N, Chiang CM and Wang H: Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein. Nucleic Acids Res. 48:5684–5694. 2020. View Article : Google Scholar : PubMed/NCBI

Cox DBT, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J and Zhang F: RNA editing with CRISPR-Cas13. Science. 358:1019–1027. 2017. View Article : Google Scholar : PubMed/NCBI

Papageorgiou L, Cuong NT and Vlachakis D: Antibodies as stratagems against cancer. Mol Biosyst. 12:2047–2055. 2016. View Article : Google Scholar : PubMed/NCBI

Vlachakis D: Antibody clustering and 3D modelling for neurodegenerative diseases. Computational Neurodegeneration. Vlamos P, Kotsireas I and Tarnanas I: Springer; New York, NY: pp. 1–13. 2020

Altaf F, Vesely C, Sheikh AM, Munir R, Shah ST and Tariq A: Modulation of ADAR mRNA expression in patients with congenital heart defects. PLoS One. 14:e02009682019. View Article : Google Scholar : PubMed/NCBI

van der Kwast RV, Quax PH and Nossent AY: An emerging role for isomiRs and the microRNA epitranscriptome in neovascularization. Cells. 9:92019. View Article : Google Scholar

Dai DF, Chen T, Johnson SC, Szeto H and Rabinovitch PS: Cardiac aging: From molecular mechanisms to significance in human health and disease. Antioxid Redox Signal. 16:1492–1526. 2012. View Article : Google Scholar

McMahon M, Forester C and Buffenstein R: Aging through an epitranscriptomic lens. Nat Aging. 1:335–346. 2021. View Article : Google Scholar

Komal S, Zhang LR and Han SN: Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases. Biomed Pharmacother. 137:1113762021. View Article : Google Scholar

Van Haute L, Dietmann S, Kremer L, Hussain S, Pearce SF, Powell CA, Rorbach J, Lantaff R, Blanco S, Sauer S, et al: Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 7:120392016. View Article : Google Scholar : PubMed/NCBI

Bohnsack MT and Sloan KE: The mitochondrial epitranscriptome: The roles of RNA modifications in mitochondrial translation and human disease. Cell Mol Life Sci. 75:241–260. 2018. View Article : Google Scholar

Vilardo E and Rossmanith W: Molecular insights into HSD10 disease: Impact of SDR5C1 mutations on the human mitochondrial RNase P complex. Nucleic Acids Res. 43:66492015. View Article : Google Scholar

Vlachakis D, Tsagrasoulis D, Megalooikonomou V and Kossida S: Introducing Drugster: A comprehensive and fully integrated drug design, lead and structure optimization toolkit. Bioinformatics. 29:126–128. 2013. View Article : Google Scholar

Xu Z, Peng B, Cai Y, Wu G, Huang J, Gao M, Guo G, Zeng S, Gong Z and Yan Y: N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives. Biochem Pharmacol. 182:1142582020. View Article : Google Scholar : PubMed/NCBI

Tsaniras S and Vlachakis D: Diet, obesity and cancer. J Mol Biochem. 4:202016.

Cui Q, Shi H, Ye P, Li L, Qu Q, Sun G, Sun G, Lu Z, Huang Y, Yang CG, et al: m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep. 18:2622–2634. 2017. View Article : Google Scholar :

Singh B, Kinne HE, Milligan RD, Washburn LJ, Olsen M and Lucci A: Important role of FTO in the survival of rare panresistant triple-negative inflammatory breast cancer cells facing a severe metabolic challenge. PLoS One. 11:e01590722016. View Article : Google Scholar : PubMed/NCBI

Charalampopoulou M, Syrigos K, Filopoulos E, Megalooikonomou V, Vlachakis D, Chrousos G and Darviri C: Reliability and validity of the instrument newly diagnosed breast cancer stress scale in the Greek population. J Mol Biochem. 9:5–12. 2020.

Su R, Dong L, Li C, Nachtergaele S, Wunderlich M, Qing Y, Deng X, Wang Y, Weng X, Hu C, et al: R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/CEBPA signaling. Cell. 172:90–105.e23. 2018. View Article : Google Scholar

Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu H, Ni T, Zhang ZS, Zhang T, Li C, et al: Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell. 35:677–691.e10. 2019. View Article : Google Scholar :

Floresta G, Pistarà V, Amata E, Dichiara M, Damigella A, Marrazzo A, Prezzavento O, Punzo F and Rescifina A: Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5′-mono-phosphate glycosidase. Chem Biol Drug Des. 91:519–525. 2018. View Article : Google Scholar

Vlachakis D, Fakourelis P, Megalooikonomou V, Makris C and Kossida S: DrugOn: A fully integrated pharmacophore modeling and structure optimization toolkit. PeerJ. 3:e7252015. View Article : Google Scholar : PubMed/NCBI

Vlachakis D and Kossida S: Molecular modeling and pharmacophore elucidation study of the Classical Swine Fever virus helicase as a promising pharmacological target. PeerJ. 1:e852013. View Article : Google Scholar : PubMed/NCBI

Papageorgiou L, Loukatou S, Sofia K, Maroulis D and Vlachakis D: An updated evolutionary study of Flaviviridae NS3 helicase and NS5 RNA-dependent RNA polymerase reveals novel invariable motifs as potential pharmacological targets. Mol Biosyst. 12:2080–2093. 2016. View Article : Google Scholar

Papageorgiou L, Loukatou S, Koumandou VL, Makałowski W, Megalooikonomou V, Vlachakis D and Kossida S: Structural models for the design of novel antiviral agents against Greek Goat Encephalitis. PeerJ. 2:e6642014. View Article : Google Scholar : PubMed/NCBI

Amidi S, Amidi A, Vlachakis D, Paragios N and Zacharaki EI: Automatic single- and multi-label enzymatic function prediction by machine learning. PeerJ. 5:e30952017. View Article : Google Scholar : PubMed/NCBI

Marinou M, Platis D, Ataya FS, Chronopoulou E, Vlachakis D and Labrou NE: Structure-based design and application of a nucleotide coenzyme mimetic ligand: Application to the affinity purification of nucleotide dependent enzymes. J Chromatogr A. 1535:88–100. 2018. View Article : Google Scholar

Vlachakis D and Vlamos P: Mathematical multidimensional modelling and structural artificial intelligence pipelines provide insights for the designing of highly specific antiSARS-CoV2 agents. Math Comput Sci. 15:877–888. 2021. View Article : Google Scholar